Vaginal atrophy. Postmenopausal atrophic vaginitis
Conditions
Interventions
Intervention 1: Treatment group received the vitamin D 200 IU vaginal suppository in 8 weeks. They use it every night in first two weeks and every other day in later six-weeks. Intervention 2: Control
Placebo
Treatment - Drugs
Treatment group received the vitamin D 200 IU vaginal suppository in 8 weeks. They use it every night in first two weeks and every other day in later six-weeks.
Control group recieved plasbo vaginal suppository in 8 weeks. They use it every night in first two weeks and every other day in later six-weeks.
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
44 Years to 64 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: aged between 16 - 64 years; Laboratory confirmation of menopause; at least one year after the last menstruation. Exclusion criteria: hormonal treatment; intravaginal drug; existence of vaginal infection.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maturation index. Timepoint: two timews, the first and last visit. Method of measurement: pap smear. | — |
Secondary
| Measure | Time frame |
|---|---|
| PH. Timepoint: PH. Method of measurement: PH meter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParastou rad
Ahvaz University of Medical Sciences
Outcome results
None listed